arrow
M

Mohammed Alruwaili

Northern Border University
H-index:5
Citation Count:102
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer

FHL1下调特异性针对癌相关成纤维细胞,并与结直肠癌中染色质可及性降低相关

Genes
IF2.8
2026-09-300
OA
Gasdermin proteins as pyroptosis-based biomarkers in ovarian cancer: Diagnostic and prognostic utility

Gasdermin蛋白作为基于焦亡的卵巢癌生物标志物:诊断和预后价值

2026-09-150
PRE
Development and Optimization of Sodium Deoxycholate-Stabilised Shellac-Based Polymeric Nanoparticles for Enhanced Pharmacokinetics and Anticancer Activity of Etodolac in Hepatocellular Carcinoma

牛磺脱氧胆酸钠稳定的虫胶基聚合物纳米粒的制备与优化:用于提高依托考昔在肝细胞癌中的药代动力学和抗肿瘤活性

2026-07-300
OA
Neoadjuvant PD-1-Based Immunotherapy in Localized dMMR/MSI-H Colorectal Cancer: A Systematic Review and Arm-Based Meta-Analysis
Cancers
IF4.4
2026-07-300
OA
Multi-omics profiling of oxeiptosis-associated biomarkers in cancer

癌症中氧昔体溶解相关生物标志物的多组学分析

2026-06-010
PRE
Exploring the role of PARP9 expression in AML: prognostic implications and transcriptomic insights

探究PARP9表达在AML中的角色:预后意义和转录组学见解

2026-03-310
PRE
The ameliorative effects of propolis and/or levothyroxine on propylthiouracil-induced hypothyroidism in adult albino rats
2025-10-010
OAAI
Harmonic Mean Optimizer (HMO) for global problems solving
2024-11-010
PRE
A synergistic two-drug therapy selectively targeting DNA repair dysregulation in p53-deficient cancers
2024-10-010
PRE
Novel therapeutic approach for targeting p53 mutant colorectal cancers by affecting post-replicative DNA repair
2024-03-220
PRE
The role of p38 MAPK in the tumor-induced immune suppressive microenvironment in metastatic breast cancer
2024-03-220
PRE
A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers
2024-03-014
OAAI
Evaluation of a novel two-drug combination strategy for p53-deficient colorectal and pancreatic cancers
2023-04-040
PRE
Blockade of p38 MAPK reduces the tumor-induced immune suppressive microenvironment in metastatic breast cancer
2023-04-040
PRE
A synthetic lethality treatment strategy for p53 mutant breast cancer
2022-02-150
PRE
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair
2021-07-128
OAAI
Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells
2018-09-0124
PREAI